NCT04827147View on ClinicalTrials.gov

Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia

NAActive, not recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Homonymous Hemianopia
Interventions
DEVICE

Multi-Periscopic Prism (MPP) glasses

Spectacles with multi-periscopic prisms mounted as oblique peripheral prism segments

DEVICE

Fresnel Peripheral Prism (FPP) glasses

Spectacles with conventional permanent Fresnel prisms mounted as oblique peripheral prism segments

Trial Locations (8)

33461

Visual Health and Surgical Center, Palm Springs

35233

UAB Center for Low Vision Rehabilitation, Callahan Eye Hospital, Birmingham

60616

Illinois College of Optometry, Chicago

80045

UCHealth Sue Anschutz-Rodgers Eye Center, Denver

02114

Schepens Eye Research Institute, Boston

02215

New England College of Optometry, Boston

01608

The Eye and Vision Center at MCPHS, Worcester

01655

UMass Chan Medical School, Worcester

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Massachusetts Eye and Ear Infirmary

OTHER